HealthData.Gov
Development of Dengue virus type 2 replicons capable of prolonged expression in host cells
Background As part of a program to develop a Dengue virus vaccine which avoids the deleterious effects of antibody dependent enhancement (ADE) of infection mediated by antibodies to Dengue virus structural proteins, we…
- HTML
Updated Oct 29, 2026